Literature DB >> 15961206

Ruling in and ruling out: implications of molecular genetic diagnoses for disease classification.

Fiona Alice Miller1, Catherine Ahern, Jacqueline Ogilvie, Mita Giacomini, Lisa Schwartz.   

Abstract

We report on a qualitative analysis of interviews with 14 genetic counsellors in Ontario, Canada about the implications of developments in molecular genetic knowledge for disease definition and classification. Genetic counsellors express a restrained set of hopes and expectations about the utility of genetic diagnoses. They identify several limitations faced by available genetic tests, limitations that constrain the significance of genetic information in disease identification and clinical management. Yet they also emphasize the fundamental nature of genetic information, its decisive role in specifying disease causation, and its significance for disease classification. The decisive nature of genetic information means that, in some cases, genetic tests foster change in disease categories. Diseases are redefined by the "ruling in" of atypical cases demonstrating a broader spectrum of clinical effects, or the "ruling out" of typical cases with classic clinical presentations that are better assigned to other (or no) causes. These redefinitions can be profoundly consequential, producing several kinds of uncertainty: What do we call this state of being? How do we manage it clinically? And, what are the social entitlements of individuals in this state? Though limited today, such complex effects can be expected to increase, alongside the growing diagnostic power of molecular genetics.

Mesh:

Year:  2005        PMID: 15961206     DOI: 10.1016/j.socscimed.2005.04.043

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  5 in total

1.  What is a meaningful result? Disclosing the results of genomic research in autism to research participants.

Authors:  Fiona Alice Miller; Robin Zoe Hayeems; Jessica Peace Bytautas
Journal:  Eur J Hum Genet       Date:  2010-03-17       Impact factor: 4.246

2.  A qualitative study of patients' perceptions of the value of molecular diagnosis for familial hypercholesterolemia (FH).

Authors:  Nina Hallowell; Nicholas Jenkins; Margaret Douglas; Simon Walker; Robert Finnie; Mary Porteous; Julia Lawton
Journal:  J Community Genet       Date:  2016-11-19

3.  "Set in Stone" or "Ray of Hope": Parents' Beliefs About Cause and Prognosis After Genomic Testing of Children Diagnosed with ASD.

Authors:  Marian Reiff; Eva Bugos; Ellen Giarelli; Barbara A Bernhardt; Nancy B Spinner; Pamela L Sankar; Surabhi Mulchandani
Journal:  J Autism Dev Disord       Date:  2017-05

4.  A place for genetic uncertainty: parents valuing an unknown in the meaning of disease.

Authors:  Ian Whitmarsh; Arlene M Davis; Debra Skinner; Donald B Bailey
Journal:  Soc Sci Med       Date:  2007-06-11       Impact factor: 4.634

5.  Patient accounts of diagnostic testing for familial hypercholesterolaemia: comparing responses to genetic and non-genetic testing methods.

Authors:  Gareth J Hollands; David Armstrong; Angela Macfarlane; Martin A Crook; Theresa M Marteau
Journal:  BMC Med Genet       Date:  2012-09-21       Impact factor: 2.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.